Literature DB >> 20231524

How does smoking reduce the risk of preeclampsia?

S Ananth Karumanchi, Richard J Levine.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20231524      PMCID： PMC2855389          DOI： 10.1161/HYPERTENSIONAHA.109.148973

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  14 in total

1.  Smoking in moderate/severe preeclampsia worsens pregnancy outcome, but smoking cessation limits the damage.

Authors:  F Broughton Pipkin
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

Review 2.  Pathogenesis of preeclampsia.

Authors:  Brett C Young; Richard J Levine; S Ananth Karumanchi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

3.  Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast.

Authors:  Shannon A Bainbridge; Louiza Belkacemi; Michelle Dickinson; Charles H Graham; Graeme N Smith
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

4.  Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff.

Authors:  Anna-Karin Wikström; Olof Stephansson; Sven Cnattingius
Journal:  Hypertension       Date:  2010-03-15       Impact factor: 10.190

5.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Authors:  Richard J Levine; Chun Lam; Cong Qian; Kai F Yu; Sharon E Maynard; Benjamin P Sachs; Baha M Sibai; Franklin H Epstein; Roberto Romero; Ravi Thadhani; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

6.  The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction.

Authors:  S Cnattingius; J L Mills; J Yuen; O Eriksson; H Salonen
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

7.  Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia.

Authors:  Arun Jeyabalan; Robert W Powers; Allison R Durica; Gail F Harger; James M Roberts; Roberta B Ness
Journal:  Am J Hypertens       Date:  2008-06-19       Impact factor: 2.689

8.  Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia.

Authors:  Antonio Farina; Akihiko Sekizawa; Paola De Sanctis; Yuditiya Purwosunu; Takashi Okai; Dong Hyun Cha; Jin Hee Kang; Claudia Vicenzi; Annalisa Tempesta; Noroyono Wibowo; Luisella Valvassori; Nicola Rizzo
Journal:  Prenat Diagn       Date:  2008-10       Impact factor: 3.050

9.  End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia.

Authors:  Doron Kreiser; Micha Baum; Daniel S Seidman; Avery Fanaroff; Dinesh Shah; Israel Hendler; David K Stevenson; Eyal Schiff; Maurice L Druzin
Journal:  J Perinatol       Date:  2004-04       Impact factor: 2.521

10.  Adverse pregnancy outcomes in snuff users.

Authors:  Lucinda J England; Richard J Levine; James L Mills; Mark A Klebanoff; Kai F Yu; Sven Cnattingius
Journal:  Am J Obstet Gynecol       Date:  2003-10       Impact factor: 8.661
View more
  23 in total

1.  The role of FAS, FAS-L, BAX, and BCL-2 gene polymorphisms in determining susceptibility to unexplained recurrent pregnancy loss.

Authors:  Rafael Tomoya Michita; Francis Maria Báo Zambra; Lucas Rosa Fraga; Maria Teresa Sanseverino; Lavínia Schuler-Faccini; José Artur Bogo Chies; Priscila Vianna
Journal:  J Assist Reprod Genet       Date:  2019-04-02       Impact factor: 3.412

2.  Deconstructing the smoking-preeclampsia paradox through a counterfactual framework.

Authors:  Miguel Angel Luque-Fernandez; Helga Zoega; Unnur Valdimarsdottir; Michelle A Williams
Journal:  Eur J Epidemiol       Date:  2016-03-14       Impact factor: 8.082

3.  Maternal angiogenic profile in pregnancies that remain normotensive.

Authors:  Jessica M Faupel-Badger; Anne Cathrine Staff; Ravi Thadhani; Camille E Powe; Nancy Potischman; Robert N Hoover; Rebecca Troisi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-10       Impact factor: 2.435

Review 4.  Hypertensive disorders in pregnancy.

Authors:  Casey Berry; Mohamed G Atta
Journal:  World J Nephrol       Date:  2016-09-06

5.  Midpregnancy levels of angiogenic markers in relation to maternal characteristics.

Authors:  Renée S Mijal; Claudia B Holzman; Sarosh Rana; S Ananth Karumanchi; Jianling Wang; Alla Sikorskii
Journal:  Am J Obstet Gynecol       Date:  2010-12-10       Impact factor: 8.661

6.  Maternal active and passive smoking and hypertensive disorders of pregnancy: risk with trimester-specific exposures.

Authors:  Stephanie M Engel; Erica Scher; Sylvan Wallenstein; David A Savitz; Elin R Alsaker; Lill Trogstad; Per Magnus
Journal:  Epidemiology       Date:  2013-05       Impact factor: 4.822

7.  Effect of smoking on circulating angiogenic factors in high risk pregnancies.

Authors:  Arun Jeyabalan; Robert W Powers; Rebecca G Clifton; Peter Van Dorsten; John C Hauth; Mark A Klebanoff; Marshall D Lindheimer; Baha Sibai; Mark Landon; Menachem Miodovnik
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  Pre-eclampsia in American Indians/Alaska Natives and Whites: The Significance of Body Mass Index.

Authors:  Anna Zamora-Kapoor; Lonnie A Nelson; Dedra S Buchwald; Leslie R Walker; Beth A Mueller
Journal:  Matern Child Health J       Date:  2016-11

9.  Effects of maternal smokeless tobacco use on selected pregnancy outcomes in Alaska Native women: a case-control study.

Authors:  Lucinda J England; Shin Y Kim; Carrie K Shapiro-Mendoza; Hoyt G Wilson; Juliette S Kendrick; Glen A Satten; Claire A Lewis; Myra J Tucker; William M Callaghan
Journal:  Acta Obstet Gynecol Scand       Date:  2013-03-29       Impact factor: 3.636

Review 10.  Pre-eclampsia and cardiovascular disease.

Authors:  Christina W Chen; Iris Z Jaffe; S Ananth Karumanchi
Journal:  Cardiovasc Res       Date:  2014-02-13       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.